The Enterprise Value as of December 2025 (TTM) for EyePoint Pharmaceuticals, Inc. (EYPT) is 1.09B

According to EyePoint Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.09B. This represents a change of 92.38% compared to the average of 568.69M of the last 4 quarters.

EyePoint Pharmaceuticals, Inc. (EYPT) Historical Enterprise Value (quarterly & annually)

How has EYPT Enterprise Value performed in the past?

The mean historical Enterprise Value of EyePoint Pharmaceuticals, Inc. over the last ten years is 180.85M. The current 1.09B Enterprise Value has changed 60.40% with respect to the historical average. Over the past ten years (40 quarters), EYPT's Enterprise Value was at its highest in in the September 2025 quarter at 945.92M. The Enterprise Value was at its lowest in in the December 2017 quarter at 35.22M.

EyePoint Pharmaceuticals, Inc. (EYPT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of EyePoint Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

EyePoint Pharmaceuticals, Inc. (EYPT) Average Enterprise Value

How has EYPT Enterprise Value performed in the past?

The current Enterprise Value of EyePoint Pharmaceuticals, Inc. (EYPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

EyePoint Pharmaceuticals, Inc. (EYPT) Enterprise Value vs. Peers

How is EYPT’s Enterprise Value compared to its peers?

EyePoint Pharmaceuticals, Inc.’s Enterprise Value is less than ProKidney Corp. (1.56B), greater than Kura Oncology, Inc. (961.31M), greater than Bicara Therapeutics Inc. Common Stock (593.30M), less than Kodiak Sciences Inc. (1.30B), greater than Tango Therapeutics, Inc. (1.09B), greater than Septerna, Inc. (875.41M), greater than Prime Medicine, Inc. (728.20M), less than Savara Inc. (1.31B), greater than Rezolute, Inc. (891.81M), less than Nurix Therapeutics, Inc. (1.36B),

Build a custom stock screener for EyePoint Pharmaceuticals, Inc. (EYPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EyePoint Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

EyePoint Pharmaceuticals, Inc. (EYPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like EyePoint Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.